Specifically, peripheral blockade and hepatic deletion/overexpression of CB1R modulate the expression levels of the sOb-R isoform in hepatocytes and its subsequent release into the circulation, reversing the CB1R-mediated decrease in sOb-R levels and hepatic leptin resistance during obesity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.